Mettler-Toledo International (NYSE:MTD – Get Free Report) had its target price raised by analysts at Stifel Nicolaus from $1,600.00 to $1,900.00 in a research report issued to clients and investors on Monday, Benzinga reports. The firm presently has a “buy” rating on the medical instruments supplier’s stock. Stifel Nicolaus‘s target price would indicate a potential upside of 10.25% from the company’s previous close.
A number of other brokerages also recently issued reports on MTD. Robert W. Baird lifted their price target on shares of Mettler-Toledo International from $1,608.00 to $1,815.00 and gave the company a “neutral” rating in a report on Monday. Jefferies Financial Group boosted their price target on shares of Mettler-Toledo International from $1,400.00 to $1,580.00 and gave the stock a “buy” rating in a research note on Friday, July 31st. Royal Bank Of Canada began coverage on shares of Mettler-Toledo International in a report on Tuesday, September 1st. They set a “sector perform” rating and a $1,515.00 price objective for the company. Morgan Stanley increased their price objective on shares of Mettler-Toledo International from $1,450.00 to $1,575.00 and gave the company an “equal weight” rating in a report on Tuesday, October 13th. Finally, UBS Group started coverage on Mettler-Toledo International in a research report on Wednesday, September 9th. They set a “neutral” rating and a $1,460.00 price objective for the company. Six investment analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $1,540.00.
Check Out Our Latest Analysis on MTD
Mettler-Toledo International Trading Up 0.1%
Mettler-Toledo International stock opened at $1,723.32 on Monday. The stock has a market cap of $34.53 billion, a P/E ratio of 37.34, a PEG ratio of 3.46 and a beta of 1.16. The company has a debt-to-equity ratio of 25.28, a current ratio of 1.10 and a quick ratio of 0.75. Mettler-Toledo International has a 1 year low of $1,023.05 and a 1 year high of $1,806.58. The firm’s 50 day moving average price is $1,524.65 and its 200-day moving average price is $1,345.95.
Mettler-Toledo International (NYSE:MTD – Get Free Report) last released its earnings results on Thursday, November 5th. The medical instruments supplier reported $12.57 EPS for the quarter, topping the consensus estimate of $12.13 by $0.44. Mettler-Toledo International had a net margin of 22.25% and a return on equity of 15,012.71%. The firm had revenue of $1.09 billion for the quarter, compared to the consensus estimate of $1.07 billion. During the same quarter in the previous year, the firm earned $11.15 earnings per share. The company’s quarterly revenue was up 6.3% compared to the same quarter last year. On average, equities analysts predict that Mettler-Toledo International will post 47.49 earnings per share for the current fiscal year.
Insiders Place Their Bets
In related news, CEO Patrick Kaltenbach sold 942 shares of the stock in a transaction on Thursday, August 27th. The stock was sold at an average price of $1,425.00, for a total transaction of $1,342,350.00. Following the sale, the chief executive officer owned 4,480 shares in the company, valued at approximately $6,384,000. This represents a 17.37% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Insiders own 0.71% of the company’s stock.
Institutional Inflows and Outflows
Several institutional investors and hedge funds have recently bought and sold shares of the company. National Pension Service raised its stake in shares of Mettler-Toledo International by 7.9% in the second quarter. National Pension Service now owns 39,696 shares of the medical instruments supplier’s stock valued at $50,712,000 after acquiring an additional 2,916 shares during the period. Aware Super Pty Ltd as trustee of Aware Super bought a new stake in shares of Mettler-Toledo International during the 1st quarter worth approximately $26,372,000. Bank of America Corp DE bought a new stake in shares of Mettler-Toledo International during the 2nd quarter worth approximately $240,817,000. Corient Private Wealth LP boosted its holdings in Mettler-Toledo International by 421.7% during the 2nd quarter. Corient Private Wealth LP now owns 26,147 shares of the medical instruments supplier’s stock valued at $33,402,000 after acquiring an additional 21,135 shares during the period. Finally, Jefferies Financial Group Inc. purchased a new position in Mettler-Toledo International during the 2nd quarter valued at $1,283,000. 95.07% of the stock is owned by hedge funds and other institutional investors.
Mettler-Toledo International Company Profile
Mettler-Toledo International develops and manufactures precision instruments and systems used in laboratory, industrial, and retail settings. Its products include laboratory balances and analytical instruments, industrial scales and weighing systems, and equipment for measuring and monitoring production processes.
The company also supplies product-inspection systems, including checkweighers, metal detectors, and X-ray inspection equipment, along with related software, installation, maintenance, and calibration services.
Recommended Stories
- Five stocks we like better than Mettler-Toledo International
- America’s Rare Earth Clock Is Running Out, But the Bottleneck Isn’t Where You Think
- Atlassian Tanks After Huge Run as Guidance Disappoints, But Strength Remains
- Lemonade’s Revenue Soars 73%—So Why Did Its Stock Turn Sour After Earnings?
- Anthropic’s S-1 Strengthens the Case for Broadcom’s AI Growth
Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.
